Anil Rajendra is a Cardiology physician. OpenAlex indexes 100 publications with 1,015 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3680 Grandview Pkwy Ste 200
Birmingham, AL 352433411
Telephone
205-971-7500Provider last certified this registry record 10 Aug 2025.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202580 payments$101,803openpaymentsdata.cms.gov ↗
- CardioFocus, Inc.Program year20252 payments$12,495openpaymentsdata.cms.gov ↗
- Biosense Webster, Inc.Program year202532 payments$11,223openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
62.5%Antiarrhythmic30.5%Amiodarone Hcl46%Flecainide Acetate34%Multaq21%Part D≥71 patientsBeta blocker20%Sotalol36%Metoprolol Succinate29%Carvedilol22%Metoprolol Tartrate7%Sotalol Af5%Part D<11 patients+ 6 more classes in this area
Blood & clotting
35.7%Factor Xa inhibitor33.6%Eliquis88%Xarelto13%Part D≥111 patientsP2Y12 inhibitor1.1%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Anti-infectives
1.8%Penicillins with extended spectrum1.8%Amoxicillin100%Part D≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients
Journal of the American College of Cardiology
2025 - Insights Into Early Adoption and Physician Learning Curve of Pulsed Field Ablation in the United States
Circulation Arrhythmia and Electrophysiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”